View in browser


To achieve added value in imaging, there must be ways to turn better scans into actionable insights. Fortunately, advancing technology has this covered: Keep reading to find out how specific markers improve risk assessment for pathologies of the brain, and how combined technologies enable microsurgery to operate on even smaller scales. We also take a look at approaches to create a digital equivalent of the Red Cross, further changes to the IVDR, and more – enjoy browsing!

Article • Brain imaging

White matter hyperintensities: a valuable biomarker to assess mortality risk

White matter hyperintensities (WMH) on the brain seen on MRI represent a biomarker associated with a 50/50 risk of death within five years after a first incident acute ischemic stroke (AIS) or transient ischemic attack (TIA).

Article • Digitisation in the OR

Robotic duo pushes boundaries of microsurgery

One robot supports the surgeon’s control of tiny instruments, while another automatically keeps an eye on what is happening: With this novel combination, surgeons in Münster have successfully performed fully robot-assisted microsurgery for the ...


News • IT emblem proposal

Could a 'digital Red Cross' protect against cyberattacks?

The Red Cross is intended to protect aid workers from attack during their missions. Can this symbol also be used for the digital world – and what opportunities and risks are associated with it?

News • Bioelectric patterns

Scientists listen in on the ‘electrical language’ of breast cancer

New research has found variable voltages in the membranes of breast cancer cells, revealing clues about how they grow and spread.

Article • Regulatory challenges for AI-based diagnostics

Further IVDR changes: a step in the right direction, but…

New changes made to the timetable for the In vitro Diagnostic Medical Device Regulation (IVDR) across Europe could have a significant impact on manufacturers and users, an expert points out. While the extension of the transition period was a welcome ...

News • Bioprinting in cancer

3D printing patient-specific tumours

Bowel cancer patients could in future benefit from a new 3D bioprinting technology which would use their own cells to replicate the complex cellular environment of solid tumours in 3D models.

Product news


Tissue-Tek Genie Advanced Staining System – Sakura Finetek

Chemistry & immunochemistry

Fujifilm Wako – NEFA-HR(2) Assay


You are receiving this email because you subscribed to our newsletter on healthcare-in-europe

If you don’t want to receive this newsletter anymore, click here to unsubscribe.

Keep up-to-date on the latest news from all hospital-related fields!
Subscribe to our bi-monthly newsletter.

Copyright © 2023 mgo fachverlage GmbH & Co. KG.
All rights reserved.

E.-C.-Baumann-Straße 5, 95326 Kulmbach, Germany